GenSight Biologics S.A. (FRA:G49N)
0.0588
-0.0021 (-3.45%)
Last updated: Jan 30, 2026, 9:25 AM CET
GenSight Biologics Employees
GenSight Biologics had 13 employees as of June 30, 2025. The number of employees decreased by 3 or -18.75% since the number was reported on December 31, 2024.
Employees
13
Change
-3
Growth
-18.75%
Revenue / Employee
€72,692
Profits / Employee
€1,163,077
Market Cap
17.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 13 | -3 | -18.75% | 13 | 0 |
| Dec 31, 2024 | 16 | 0 | - | 16 | 0 |
| Dec 31, 2023 | 16 | -29 | -64.44% | 16 | 0 |
| Dec 31, 2022 | 45 | 7 | 18.42% | 45 | 0 |
| Dec 31, 2021 | 38 | 13 | 52.00% | 38 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |